ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9 | -99.9% | 232 | +6.9% | 0.00% | – |
| Q3 2022 | $7,000 | -85.1% | 217 | -83.8% | 0.00% | – |
| Q2 2022 | $47,000 | -79.5% | 1,340 | -73.2% | 0.00% | -100.0% |
| Q1 2022 | $229,000 | -30.4% | 4,994 | +0.5% | 0.00% | -50.0% |
| Q4 2021 | $329,000 | +145.5% | 4,971 | +131.1% | 0.00% | +100.0% |
| Q3 2021 | $134,000 | +14.5% | 2,151 | +51.6% | 0.00% | 0.0% |
| Q2 2021 | $117,000 | -77.0% | 1,419 | -81.5% | 0.00% | -66.7% |
| Q1 2021 | $509,000 | +42.2% | 7,690 | +64.6% | 0.00% | 0.0% |
| Q4 2020 | $358,000 | +79.9% | 4,672 | +1.0% | 0.00% | +50.0% |
| Q3 2020 | $199,000 | +26.8% | 4,626 | +27.6% | 0.00% | 0.0% |
| Q2 2020 | $157,000 | +70.7% | 3,626 | +13.3% | 0.00% | +100.0% |
| Q1 2020 | $92,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |